Dr. Cvijeta Bielen
Medical Director
22 February, 2017
Attendees will gain a clear understanding of how reference safety information functions during clinical development and post-approval, as well as insights into the relationship between reference safety information and product labeling. Dr. Bielen will also address common challenges in preparing these documents and share practical strategies for streamlining the process to meet regulatory standards effectively.
Medical Director
This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.